Pingping Lin
16 Jiangsu Road
Qingdao, 266003, China
Qingdao, 266003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-2010, a novel anti-MASP-2 antibody, in healthy volunteers: a randomized, double-blind, placebo-controlled phase 1 study.
Journal: Expert opinion on investigational drugs
Published: April 29, 2025
Pharmacokinetics and safety profiles of beinaglutide injection, a recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial.
Journal: Frontiers in pharmacology
Published: May 16, 2024
Randomized, Double-Blind, Placebo-Controlled, Phase I, Dose- Escalation Study to Evaluate the Tolerance, Pharmacokinetics, Pharmacodynamics and Immunogenicity of PEGylated Urate Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers: Study Protocol.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: August 10, 2023
Tolerability, safety, and pharmacokinetics of a single intravenous administration of a novel recombinant humanized anti-interleukin-6 receptor monoclonal antibody in healthy Chinese volunteers.
Journal: Frontiers in pharmacology
Published: July 26, 2023
Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
Journal: BMC pharmacology & toxicology
Published: June 30, 2022
Pharmacokinetics and safety of two Voriconazole formulations after intravenous infusion in two doses in healthy Chinese subjects.
Journal: BMC pharmacology & toxicology
Published: June 26, 2022
A Drug-Drug Interaction Study of a Novel Selective Urate Reabsorption Inhibitor, SHR4640, and Xanthine Oxidase Inhibitor, Febuxostat, in Patients With Primary Hyperuricemia.
Journal: Journal of clinical pharmacology
Published: June 25, 2022
The effect of rifampin on the pharmacokinetics of famitinib in healthy subjects.
Journal: Cancer chemotherapy and pharmacology
Published: June 21, 2022
A Randomized, Open-Label, Phase I Clinical Study of Dalpiciclib With Different Specifications After Process Modification in Healthy Chinese Volunteers.
Journal: Clinical pharmacology in drug development
Published: May 30, 2022
Safety, tolerability and pharmacokinetics of a Class I natural medicine with therapeutic potential for vascular dementia: Naoqingzhiming tablet.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 29, 2022
Bioequivalence and Food Effect Assessment of 2 Rivaroxaban Formulations in Healthy Chinese Volunteers: An Open, Randomized, Single-Dose, and 4-Period Crossover Study.
Journal: Clinical pharmacology in drug development
Published: June 07, 2021
Last Updated: 09/26/2026